BRCA1 and ovarian carcinoma: Additionally, BAs can influence the expression and activity of various PARP enzymes (24), and deoxycholic acid can regulate the expression of BRCA1 and estrogen receptors, thereby controlling the drug sensitivity of ovarian cancer cells (52).